245 related articles for article (PubMed ID: 33230295)
1. An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
Lin YH; Satani N; Hammoudi N; Yan VC; Barekatain Y; Khadka S; Ackroyd JJ; Georgiou DK; Pham CD; Arthur K; Maxwell D; Peng Z; Leonard PG; Czako B; Pisaneschi F; Mandal P; Sun Y; Zielinski R; Pando SC; Wang X; Tran T; Xu Q; Wu Q; Jiang Y; Kang Z; Asara JM; Priebe W; Bornmann W; Marszalek JR; DePinho RA; Muller FL
Nat Metab; 2020 Dec; 2(12):1413-1426. PubMed ID: 33230295
[TBL] [Abstract][Full Text] [Related]
2. Passenger deletions generate therapeutic vulnerabilities in cancer.
Muller FL; Colla S; Aquilanti E; Manzo VE; Genovese G; Lee J; Eisenson D; Narurkar R; Deng P; Nezi L; Lee MA; Hu B; Hu J; Sahin E; Ong D; Fletcher-Sananikone E; Ho D; Kwong L; Brennan C; Wang YA; Chin L; DePinho RA
Nature; 2012 Aug; 488(7411):337-42. PubMed ID: 22895339
[TBL] [Abstract][Full Text] [Related]
3. Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of
Yan VC; Pham CD; Ballato ES; Yang KL; Arthur K; Khadka S; Barekatain Y; Shrestha P; Tran T; Poral AH; Washington M; Raghavan S; Czako B; Pisaneschi F; Lin YH; Satani N; Hammoudi N; Ackroyd JJ; Georgiou DK; Millward SW; Muller FL
J Med Chem; 2022 Oct; 65(20):13813-13832. PubMed ID: 36251833
[TBL] [Abstract][Full Text] [Related]
4. Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer.
Qian X; Xu W; Xu J; Shi Q; Li J; Weng Y; Jiang Z; Feng L; Wang X; Zhou J; Jin H
Oncotarget; 2017 Jul; 8(29):47691-47708. PubMed ID: 28548950
[TBL] [Abstract][Full Text] [Related]
5. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest.
Capello M; Ferri-Borgogno S; Riganti C; Chattaragada MS; Principe M; Roux C; Zhou W; Petricoin EF; Cappello P; Novelli F
Oncotarget; 2016 Feb; 7(5):5598-612. PubMed ID: 26734996
[TBL] [Abstract][Full Text] [Related]
7. Enolase-1 is a therapeutic target in endometrial carcinoma.
Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
[TBL] [Abstract][Full Text] [Related]
8. Aspirin modulates 2-hydroxyisobutyrylation of ENO1K281 to attenuate the glycolysis and proliferation of hepatoma cells.
Yuan Y; Yuan HF; Geng Y; Zhao LN; Yun HL; Wang YF; Yang G; Zhang XD
Biochem Biophys Res Commun; 2021 Jun; 560():172-178. PubMed ID: 34000466
[TBL] [Abstract][Full Text] [Related]
9. Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway.
Sun L; Lu T; Tian K; Zhou D; Yuan J; Wang X; Zhu Z; Wan D; Yao Y; Zhu X; He S
Eur J Pharmacol; 2019 Feb; 845():8-15. PubMed ID: 30582908
[TBL] [Abstract][Full Text] [Related]
10. [Small interfering RNA-mediated α-enolase knockdown suppresses glycolysis and proliferation of human glioma U251 cells in vitro].
Luo QS; Fu HD; Huang HN; Huang HD; Luo KX; Li CY; Qin CJ; Li XY; Luo HC; Wang JL; Tang QL
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Nov; 37(11):1484-1488. PubMed ID: 29180328
[TBL] [Abstract][Full Text] [Related]
11. WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma.
Chen S; Zhang Y; Wang H; Zeng YY; Li Z; Li ML; Li FF; You J; Zhang ZM; Tzeng CM
Cell Death Dis; 2018 Mar; 9(3):347. PubMed ID: 29497031
[TBL] [Abstract][Full Text] [Related]
12. Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma.
Khadka S; Arthur K; Barekatain Y; Behr E; Washington M; Ackroyd J; Crowley K; Suriyamongkol P; Lin YH; Pham CD; Zielinski R; Trujillo M; Galligan J; Georgiou DK; Asara J; Muller F
Cancer Metab; 2021 Jun; 9(1):27. PubMed ID: 34172075
[TBL] [Abstract][Full Text] [Related]
13. Enolase 1, a Moonlighting Protein, as a Potential Target for Cancer Treatment.
Qiao G; Wu A; Chen X; Tian Y; Lin X
Int J Biol Sci; 2021; 17(14):3981-3992. PubMed ID: 34671213
[TBL] [Abstract][Full Text] [Related]
14. The immunoregulatory role of alpha enolase in dendritic cell function during Chlamydia infection.
Ryans K; Omosun Y; McKeithen DN; Simoneaux T; Mills CC; Bowen N; Eko FO; Black CM; Igietseme JU; He Q
BMC Immunol; 2017 May; 18(1):27. PubMed ID: 28525970
[TBL] [Abstract][Full Text] [Related]
15. Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.
Cancemi P; Buttacavoli M; Roz E; Feo S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31416219
[TBL] [Abstract][Full Text] [Related]
16. Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis.
Yang T; Shu X; Zhang HW; Sun LX; Yu L; Liu J; Sun LC; Yang ZH; Ran YL
Cell Death Dis; 2020 Oct; 11(10):870. PubMed ID: 33067426
[TBL] [Abstract][Full Text] [Related]
17. Up-Regulation of ENO1 by HIF-1α in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion.
Zheng F; Jang WC; Fung FK; Lo AC; Wong IY
PLoS One; 2016; 11(2):e0147961. PubMed ID: 26882120
[TBL] [Abstract][Full Text] [Related]
18. Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.
Principe M; Borgoni S; Cascione M; Chattaragada MS; Ferri-Borgogno S; Capello M; Bulfamante S; Chapelle J; Di Modugno F; Defilippi P; Nisticò P; Cappello P; Riganti C; Leporatti S; Novelli F
J Hematol Oncol; 2017 Jan; 10(1):16. PubMed ID: 28086938
[TBL] [Abstract][Full Text] [Related]
19. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
20. Expression of
Dinh DTD; Kuhl S; Görtz L; Goldbrunner R; Timmer M
Anticancer Res; 2022 May; 42(5):2319-2326. PubMed ID: 35489746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
